|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rheumatic diseases clinics of North America显示文摘 | Keystone E Wherry J Grint P | 1998 | Rheu Dis Clin Noth Am1998，24，3： | 1 |
| 2 | Golimumab 3 -year safety update: an analysis of pooled data from the longterm extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis 显示文摘 | KAY J FLEISCHMANN R KEYSTONE E | 2013 | Ann Rheum Dis2013，16，： | 1 |
| 3 | Phase separation of dilute mixture of He^4 in He^3 显示文摘 | Brewer D F Keyston J G | 1962 | Physics Letters1962，1，1： | 1 |
| 4 | IL-]O as a therapeutic strategy in the treatment of rheumatoid arthritis 显示文摘 | Keystone E Wherry J Grint P | 1998 | Rheum Dis Clin North Am1998，24，3： | 1 |
| 5 | Developing an effective treatment algo- rithm for rheumatoid arthritis显示文摘 | Keystone EC Smolen J | 2012 | Rheumatology(Oxford)2012，51，5： | 1 |
| 6 | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 显示文摘 | Furst DE Keystone EC Braun J | 2011 | Ann Rheum Dis2011，70，1： | 1 |
| 7 | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010显示文摘 | Furst DE Keystone E C Braun J etal | 2011 | Ann Rheum Dis2011，70，1： | 1 |
| 8 | Developing an effective treatment algorithmforrheumatoid arthritis 显示文摘 | Keystone EC Smolen J van Riel P | 2012 | Rheumatology ( Oxford )2012，515，： | 1 |
| 9 | IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis显示文摘 | Keystone E Wherry J Grint P | 1998 | Rheum Dis Clin North Am1998，24，3： | 1 |
| 10 | Updated Consen- sus Statement on Biological Agents for the Treatment of Rheumatic Diseases,2011显示文摘 | Furst D E Keystone E C Braun J | 2012 | Ann Rheum Dis2012，71，12： | 1 |
| 11 | Vaccination of Lravelers against hepatitis A and B 显示文摘 | Loscher T Keystone J S Steffen R | 1999 | J Travel Med1999，6，2： | 1 |
| 12 | Rheumatic diseases clinics of north america 显示文摘 | Keystone E Wherry J Grint P | 1998 | Rheu Dis Clin Noth Am1998，24，3： | 1 |
| 13 | Alefacept in comhi- nation with methotrexate for the treatment of psoriatic arthri- tis: Results of a randomized, double-blind, placebn-controlled sludy显示文摘 | Mease P J Gladman D D Keystone E C | 2006 | Arthritis Rheum2006，54，： | 1 |
| 14 | Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid art-hritis:findings of a fifty-two-week,phase Ⅲ,multicenter,randomized,doubleblind,placebo-controlled,parallel-group study显示文摘 | Keystone E Heijde D Mason D J | 2008 | Arthritis Rheum2008，58，： | 1 |
| 15 | Global distribution of a vari- ant of the circumsporozoite gene of Plasmodiuin vivax显示文摘 | Kain KC Keystone J Franke ED | 1991 | J Infect Dis1991，164，： | 1 |
| 16 | The safety of anti-tumor necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events 显示文摘 | LEOMBRUNO J P EINARSON T R KEYSTONE E C | 2009 | Ann Rheum Dis2009，68，7： | 1 |
| 17 | Radiographic, clini- cal, and functional outcomes of treatment with adalimumab( a human an- ti - tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a ran- domized, placebo - controlled, 52 - week trial 显示文摘 | Keystone E C Kavanaugh A F Sharp J T | 2004 | Arthritis Rheum2004，50，： | 1 |
| 18 | The safety of anti tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events 显示文摘 | Leombruno J P Einarson T R Keystone E C | 2009 | Ann Rheum Dis2009，68，7： | 1 |
| 19 | Updated con-sensus statement on biological agents for the treatment ofrheumatic diseases,2011 显示文摘 | FURST D E KEYSTONE E C BRAUN J | 2012 | Ann Rheum Dis2012，71，2： | 1 |
| 20 | Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo- controlled study 显示文摘 | Mease P J Gladman DD Keystone EC | 2006 | Arthritis Rheum2006，54，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员